Profile data is unavailable for this security.
About the company
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
- Revenue in HKD (TTM)6.47bn
- Net income in HKD1.37bn
- Incorporated2004
- Employees5.80k
- LocationSSY Group LtdRooms 4902-03, 49th Floor, Central Plaza18 Harbour RoadWanchai Hong KongHKG
- Phone+852 26880869
- Fax+852 27873338
- Websitehttp://www.ssygroup.com.hk/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Tong Ren Tang Chinese Medicine | 1.38bn | 494.14m | 6.82bn | 779.00 | 13.81 | 1.79 | 11.03 | 4.96 | 0.5903 | 0.5903 | 1.64 | 4.55 | 0.3284 | 0.3554 | 3.62 | 1,725,133.00 | 12.72 | 16.71 | 14.09 | 18.75 | 72.06 | 69.88 | 38.72 | 40.72 | 9.55 | -- | 0.0327 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Tong Ren Tang Technologies Co Ltd | 7.41bn | 701.46m | 6.88bn | 4.01k | 9.80 | 0.8993 | 4.90 | 0.9279 | 0.5477 | 0.5477 | 5.79 | 5.97 | 0.5026 | 0.9881 | 5.22 | 1,807,516.00 | 7.42 | 7.68 | 11.69 | 12.32 | 40.97 | 43.50 | 14.76 | 16.11 | 2.30 | -- | 0.1968 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
| China Shineway Pharmaceutical Group Ltd | 4.53bn | 1.19bn | 7.23bn | 3.23k | 5.55 | 0.914 | 5.25 | 1.59 | 1.58 | 1.58 | 6.00 | 9.56 | 0.4476 | 1.28 | 5.26 | 1,318,957.00 | 11.76 | 8.03 | 15.47 | 9.77 | 75.21 | 74.55 | 26.27 | 17.87 | 3.14 | -- | 0.0457 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Consun Pharmaceutical Group Ltd | 2.95bn | 901.53m | 7.35bn | 3.18k | 7.74 | 1.83 | 7.44 | 2.49 | 1.12 | 1.12 | 3.66 | 4.72 | 0.5209 | 2.00 | 12.89 | 944,116.40 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 5.97bn | 1.78bn | 7.90bn | 4.89k | 4.45 | 0.846 | 3.83 | 1.32 | 2.02 | 2.02 | 6.79 | 10.61 | 0.4272 | 2.50 | 3.74 | 1,293,143.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 50.79 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.28bn | 9.80bn | 1.56k | -- | 2.59 | -- | 7.68 | -1.06 | -1.06 | 1.05 | 3.12 | 0.1462 | 0.6325 | 1.10 | 785,948.40 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.37bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 103.03 | -- | -18.15 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.81bn | 830.46m | 10.50bn | 5.23k | 12.64 | 0.7479 | 6.28 | 1.54 | 0.2208 | 0.2208 | 1.81 | 3.73 | 0.236 | 2.44 | 3.02 | 1,291,299.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| Shanghai Henlius Biotech Inc | 6.08bn | 746.25m | 11.14bn | 3.55k | 14.97 | 4.01 | 9.74 | 1.83 | 1.37 | 1.37 | 11.14 | 5.11 | 0.5764 | 1.90 | 6.82 | 1,671,636.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 7.60 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| SSY Group Ltd | 6.47bn | 1.37bn | 11.45bn | 5.80k | 8.43 | 1.58 | 6.26 | 1.77 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| China Traditional Chinese Med Hldg CoLtd | 18.54bn | 988.87m | 11.78bn | 17.72k | 11.92 | 0.5116 | 5.23 | 0.6355 | 0.1964 | 0.1964 | 3.68 | 4.57 | 0.453 | 1.54 | 1.82 | 1,071,720.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
| Everest Medicines Ltd | 451.14m | -1.14bn | 11.81bn | 520.00 | -- | 2.45 | -- | 26.19 | -3.52 | -3.52 | 1.40 | 14.82 | 0.0756 | 5.23 | 3.22 | 1,044,315.00 | -19.03 | -30.52 | -20.21 | -33.14 | 75.74 | -- | -251.64 | -5,745.25 | 4.62 | -- | 0.1119 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| 3SBio Inc | 9.08bn | 1.79bn | 13.99bn | 5.61k | 7.96 | 0.9023 | 6.31 | 1.54 | 0.7339 | 0.7339 | 3.73 | 6.47 | 0.3575 | 1.52 | 6.87 | 1,677,561.00 | 7.25 | 7.44 | 10.26 | 9.29 | 85.94 | 82.91 | 20.27 | 21.50 | 1.57 | 141.55 | 0.1998 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
Data as of Nov 13 2024. Currency figures normalised to SSY Group Ltd's reporting currency: Hong Kong Dollar HKD
9.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management (Hong Kong) Ltd.as of 01 Nov 2024 | 61.58m | 2.08% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 52.99m | 1.79% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 35.89m | 1.21% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 24.49m | 0.83% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 22.18m | 0.75% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2024 | 19.36m | 0.66% |
| FIL Investment Management (Singapore) Ltd.as of 31 Jul 2024 | 17.97m | 0.61% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 17.01m | 0.58% |
| FIL Investment Management (Hong Kong) Ltd.as of 30 Sep 2024 | 14.35m | 0.49% |
| Nordea Investment Management AB (Denmark)as of 30 Aug 2024 | 12.56m | 0.43% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
